We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CurveBeam AI Announces FDA Breakthrough Device Designation for Bone Fragility Software
CurveBeam AI Announces FDA Breakthrough Device Designation for Bone Fragility Software
OssView, medical diagnostic software that calculates bone microstructural deterioration, has received Breakthrough Device Designation from the FDA, according to developer CurveBeam AI of Hatfield, Penn. The designation will give the investigational software a prioritized 510(k) application review.